Captor Therapeutics S.A. (CTX) — Capital Reinvestment Ratio
Captor Therapeutics S.A. (CTX) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow (zł23.06 Million) in capital expenditures (zł83.00K). See CTX net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Captor Therapeutics S.A. Capital Reinvestment Ratio (2019–2019)
This chart tracks Captor Therapeutics S.A.'s Capital Reinvestment Ratio across 1 annual periods. Check Captor Therapeutics S.A. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Captor Therapeutics S.A. (2019–2019)
Year-by-year Capital Reinvestment Ratio for Captor Therapeutics S.A. from 2019 to 2019. For live market cap and broader valuation context, see Captor Therapeutics S.A. (CTX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.05x | zł4.39 Million | zł229.00K | — |